192MO Primary endpoint of ROSALINE: A phase II neoadjuvant study of endocrine therapy (ET) and entrectinib in invasive lobular breast carcinoma (ILBC)

Authors:
  • SLS. Lobo-Martins
    S. Lobo-Martins
  • EAE. Agostinetto
    E. Agostinetto
  • FDF.P. Duhoux
    F.P. Duhoux
  • JMJ.T.L. Ribeiro Mourato
    J.T.L. Ribeiro Mourato
  • PNP. Neven
    P. Neven
  • CBC. Chakiba Brugere
    C. Chakiba Brugere
  • JCJ-L. Canon
    J-L. Canon
  • FCF. Coussy
    F. Coussy
  • DTD. Taylor
    D. Taylor
  • CFC. Fontaine
    C. Fontaine
  • HDH. Denys
    H. Denys
  • MHM. Houinsou Hans
    M. Houinsou Hans

Abstract
No abstract available